The local effects of estradiol benzoate (EB) on mammary growth were investigated. The pellet of EB mixed with cholesterol at several ratios was implanted in the fat pad of the right third thoracic gland of the ovariectomized 3-month-old Sprague-Dawley female rat. The contralateral gland was served as the control. All the rats given EB pellets showed estrous smears for several days and subsequently continued diestrous smears. Seven-10 days after the onset of diestrus, some rats were killed by decapitation.
Synopsis
The local effects of estradiol benzoate (EB) on mammary growth were investigated. The pellet of EB mixed with cholesterol at several ratios was implanted in the fat pad of the right third thoracic gland of the ovariectomized 3-month-old Sprague-Dawley female rat. The contralateral gland was served as the control. All the rats given EB pellets showed estrous smears for several days and subsequently continued diestrous smears. Seven-10 days after the onset of diestrus, some rats were killed by decapitation.
The other rats were further grafted with the isologous pituitaries under the right kidney capsule and were killed after 20 days. By the observation of the whole mount preparation and the determination of mammary DNA, the mammary gland was found to be promoted in the growth only around the implanted pellet in the rat bearing both EB pellet at the ratio of 1: 5,000 and graft of 2 pituitaries.
On the other hand, at all dose levels examined, EB implant alone did not induce mammary growth. These results indicate that EB increases the mammary response to pituitary mammotropic hormones even in its amount which did not promote by itself the mammary growth at all, and provide evidence that one of the actions of estrogen on mammary growth is to sensitize the gland to pituitary mammotropic hormones.
The pituitary and ovarian hormones are the most important regulators of normal mammary growth. Since ovarian hormones have little or no ability to promote mammary growth in the absence of the anterior pituitary (Lyons et al., 1958; Meites and Hopkins, 1961) , whereas anterior pituitary hormones are effective in the absence of the steroid hormones (Clifton and Furth, 1960; Meites, 1961, 1964; Dao and Gawlak, 1963; Meites and Kragt, 1964) , it can be concluded that the anterior pituitary hormones are the primary stimulators of mammary growth (Meites, 1966 (Lyons and Sako, 1940; Chamberlin et al., 1941; Nelson, 1941) . However, in these experiments, the control gland of the contralateral side also grew in some cases, al- Vaginal smear was chosen as the index whether EB implant acted only locally, because it was proved to be the most sensitive measure among several behavioral and somatic response to estrogen (Davidson et al., 1968) . The smears of all the rats given EB implants showed the temporary cornification for several days and subsequently the constant diestrous features returned, which would be due to the coating by the connective tissue of the pellet and would indicate that EB acted no longer systemically after this time.
In Experiment I, the rats were implanted EB pellets only at the ratios of 1:5,000 to 1:40,000 and killed by decapitation 7-10 days after onset of diestrus. In Experiment II, the rats with EB pellets (1:5,000 or 1:10,000) were further given graft of 1 or 2 isologous pituitaries each under the right kidney capsules 7-10 days after the onset of diestrus and killed 20 days after pituitary grafting. Bilateral thoracic third glands were removed and used for whole mount preparations in Experiments I and II. The mammary growth was examined under 10 fold magnification.
In Experiment divided into two groups 7-10 days after the onset of diestrus; one was killed immediately and another was further grafted with 2 pituitaries and killed after 20 days. implants in all the rats bearing EB pellets of 1:5,000 ( Fig. 1-A) , whereas the contralateral glands in the same rats remained almost rudimentary ( Fig. 1-B There were no differences in the anterior pituitary weights among groups in all experiments. The uterine weights were rather heavier in the rats with EB pellet implants than in the rats with cholesterol pellet implants. This would be ascribed to the after-effect of EB when it acted systemically, because the uterine weight declined drastically for a while after the cessation of estrogen administration, and subsequently the decreasing rate became much slower (Ota, personal communication).
